ESC 365 - Pathophysiology and rationale for CMIs in HCM and HFpEF

Open Access

Pathophysiology and rationale for CMIs in HCM and HFpEF

Session: Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists

Topic: Hypertrophic Cardiomyopathy

Speaker: Professor C. Maack (Wuerzburg, DE)

Sponsored by AcademicCME - Supported by an independent educational grant from Bristol Myers Squibb

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

41 presentations

6 followers

4 more presentations in this session

Epidemiology and unmet needs of oHCM in the general population - How common is heart failure?

Speaker: Professor G. Savarese (Stockholm, SE)

Maximizing targeted medical therapy for oHCM: from trials to real world

Speaker: Professor I. Olivotto (Florence, IT)

Case: challenging choice between CMIs and surgery

Speaker: Doctor M. Michels (Rotterdam, NL)

Summary

Speaker: Professor I. Olivotto (Florence, IT)

Access the full session

Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists

Speakers: Professor C. Maack, Professor G. Savarese, Professor I. Olivotto, Doctor M. Michels, Professor I. Olivotto

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources